Literature DB >> 3272225

Long-term results of conservative repair of rheumatic aortic valve insufficiency.

C M Durán1, J Alonso, L Gaite, C Alonso, J C Cagigas, L Marce, M G Fleitas, J M Revuelta.   

Abstract

From July 1974 to January 1986, 50 patients underwent conservative repair for rheumatic aortic valvular disease at our institution. Eleven were male and 39 female, with an average age of 39.5 years (range 17-57). The aortic lesion was associated in all cases with a predominant mitral lesion. Twenty-five also had tricuspid disease which was surgically treated in 17. Twenty-six had aortic regurgitation and 24, a mixed lesion. The surgical techniques used were: (1) commissurotomy, (2) annuloplasty, (3) cusp free edge unfolding and (4) supra-aortic crest enhancement. Two patients had one cusp extended with pericardium. There were 3 hospital deaths (6%). Six patients were lost to follow-up at different periods. Maximum follow-up was 12.58 years with a mean of 7.78 years per patient. Twelve required reoperation with 3 deaths. Three reoperations were due to failure of the mitral bioprosthesis without reoperation on the aortic valve. Of the remaining 9 patients who had aortic and mitral dysfunction, 4 had severe aortic insufficiency. The actuarial freedom from reoperation at 13 years was 75% and the overall actuarial survival was 86%. It is concluded that these surgical techniques can be applied successfully in moderate rheumatic aortic valve disease accompanying a predominant mitral lesion. This is particularly relevant when a mitral reconstruction has been performed.

Entities:  

Mesh:

Year:  1988        PMID: 3272225     DOI: 10.1016/1010-7940(88)90075-9

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

1.  Is autologous or heterologous pericardium better for valvuloplasty? A comparative study of calcification propensity.

Authors:  Wen-Jian Jiang; Yong-Chao Cui; Jin-Hua Li; Xiu-Hui Zhang; Huan-Huan Ding; Yong-Qiang Lai; Hong-Jia Zhang
Journal:  Tex Heart Inst J       Date:  2015-06-01

2.  Aortic valve repair for isolated right coronary leaflet prolapse.

Authors:  Arnar Geirsson; Clarence H Owen; Robert S Binford; Rochus K Voeller; Christopher R Burke; Jeffrey D McNeil; Lawrence M Wei; Vinay Badhwar; J Scott Rankin
Journal:  JTCVS Tech       Date:  2022-03-03

3.  Rapid anticalcification treatment for glutaraldehyde-fixed autologous tissue in cardiovascular surgery.

Authors:  Shotaro Kaneko; Susumu Isoda; Toru Aoyama; Motohiko Goda; Shota Yasuda; Taisuke Shibuya; Mai Matsumura; Hideaki Mitsui; Koji Okudela; Shinichi Suzuki; Daisuke Machida; Munetaka Masuda
Journal:  J Cardiothorac Surg       Date:  2022-05-31       Impact factor: 1.522

4.  In vivo evaluation of an in-body, tissue-engineered, completely autologous valved conduit (biovalve type VI) as an aortic valve in a goat model.

Authors:  Yoshiaki Takewa; Masashi Yamanami; Yuichiro Kishimoto; Mamoru Arakawa; Keiichi Kanda; Yuichi Matsui; Tomonori Oie; Hatsue Ishibashi-Ueda; Tsutomu Tajikawa; Kenkichi Ohba; Hitoshi Yaku; Yoshiyuki Taenaka; Eisuke Tatsumi; Yasuhide Nakayama
Journal:  J Artif Organs       Date:  2012-12-20       Impact factor: 1.731

5.  Aortic valve repair for the treatment of rheumatic aortic valve disease: a systematic review and meta-analysis.

Authors:  Meng Zhao; Yihu Tang; Luo Li; Yawei Dai; Jieyu Lu; Xiang Liu; Jingxin Zhou; Yanhu Wu
Journal:  Sci Rep       Date:  2022-01-13       Impact factor: 4.379

6.  Short-term outcomes of aortic valve neocuspidization for various aortic valve diseases.

Authors:  Gregory Khatchatourov; Mathieu van Steenberghe; Doris Goy; Mathieu Potin; Javier Orrit; François Perret; Nicolas Murith; Jean-Jacques Goy
Journal:  JTCVS Open       Date:  2021-08-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.